D Branch Moody Selected Research

D Branch Moody Research Topics

Disease

28	Tuberculosis (Tuberculoses) 01/2022 - 06/2003
21	Infections 10/2020 - 10/2003
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 03/2005
3	Skin Diseases (Skin Disease) 01/2021 - 02/2015
3	Hypersensitivity (Allergy) 10/2017 - 01/2016
3	Inflammation (Inflammations) 06/2017 - 09/2004
2	Contact Dermatitis (Eczema, Contact) 01/2020 - 10/2017
2	Communicable Diseases (Infectious Diseases) 01/2018 - 09/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017 - 06/2017
1	Persistent Infection 10/2020
1	Allergic Contact Dermatitis 01/2020
1	Food Hypersensitivity (Food Allergy) 01/2018
1	Demyelinating Diseases (Demyelinating Disease) 08/2017
1	Leprosy (Hansen's Disease) 08/2017
1	Hyperlipidemias (Hyperlipidemia) 06/2017
1	HIV Infections (HIV Infection) 02/2016
1	Atopic Dermatitis (Atopic Eczema) 02/2016
1	Venom Hypersensitivity 01/2016
1	Poisoning 02/2014
1	Hypoxia (Hypoxemia) 07/2013
1	Starvation 01/2012
1	Lyme Disease (Disease, Lyme) 03/2011
1	Granuloma 12/2009
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 03/2005
1	Neoplasms (Cancer) 11/2003
1	Pulmonary Tuberculosis 06/2003

Drug/Important Bio-Agent (IBA)

29	LipidsIBA 01/2021 - 06/2003
11	AntigensIBA 01/2022 - 06/2003
8	Proteins (Proteins, Gene)FDA Link 10/2017 - 12/2004
4	mycobactinsIBA 01/2022 - 11/2009
3	SiderophoresIBA 01/2022 - 01/2012
3	IronIBA 01/2022 - 11/2009
3	Peptides (Polypeptides)IBA 01/2020 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2016
3	VaccinesIBA 01/2019 - 10/2009
3	GlycolipidsIBA 08/2017 - 02/2012
2	1-tuberculosinyladenosineIBA 10/2020 - 01/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 09/2004
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2020 - 07/2016
2	Biological ProductsIBA 01/2018 - 10/2008
2	CytokinesIBA 06/2017 - 03/2011
2	Phospholipases (Phospholipase)IBA 01/2016 - 02/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 10/2020
1	AllergensIBA 01/2020
1	CosmeticsIBA 01/2020
1	LactamsIBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	HydrolasesIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	sulfoglycolipidsIBA 01/2018
1	SphingolipidsIBA 01/2018
1	Reactive Nitrogen SpeciesIBA 08/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2017
1	Apolipoproteins E (ApoE)IBA 06/2017
1	Isoniazid (Ftivazide)FDA LinkGeneric 07/2016
1	Filaggrin ProteinsIBA 02/2016
1	HaptensIBA 02/2016
1	VenomsIBA 01/2016
1	Wasp Venoms (Venom, Wasp)IBA 01/2016
1	CarbonIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Terpenes (Terpenoids)IBA 04/2015
1	NucleosidesIBA 04/2015
1	Indicators and Reagents (Reagents)IBA 03/2015
1	Attenuated VaccinesIBA 02/2014
1	signal peptidase II (premurein-leader peptidase)IBA 01/2013
1	EnzymesIBA 01/2013
1	Lipoproteins (Lipoprotein)IBA 01/2013
1	MetalsIBA 01/2012
1	Antiviral Agents (Antivirals)IBA 05/2011
1	C-Type Lectins (C-Type Lectin)IBA 12/2009
1	Mycolic Acids (Mycolic Acid)IBA 12/2006
1	phthiocerol dimycocerosateIBA 12/2006
1	CarbohydratesIBA 07/2006
1	EpitopesIBA 07/2006
1	Protein Isoforms (Isoforms)IBA 03/2005
1	Cell ExtractsIBA 11/2003
1	Pattern Recognition ReceptorsIBA 10/2003
1	Tuberculin (PPD)IBA 06/2003

Therapy/Procedure

2	Immunotherapy 01/2016 - 10/2008
1	Skin Care 01/2020
1	Drug Therapy (Chemotherapy) 06/2003